CliffBio
small molecule

VOLTAREN ARTHRITIS PAIN

DICLOFENAC SODIUM

Loss of exclusivity—loss of exclusivity
CompanyHaleon →See this company's full patent-cliff portfolio

Drug detail

Brand nameVOLTAREN ARTHRITIS PAIN
Active ingredientDICLOFENAC SODIUM
Strength1%
Dosage formGEL
RouteTOPICAL
ModalitySmall molecule
FDA approvalOctober 2007
Marketing statusOTC

More from Haleon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.